Abstract
Novel methods for treating diabetes mellitus and hyperglycemia are described which comprise administering to a diabetic or hypoglycemic subject an amount of an amylin agonist effective to induce amylin activity in said subject. Various amylin agonist compounds, and therapeutic methods utilizing such compounds, are also disclosed.
| Original language | English |
|---|---|
| Patent number | 5175145 |
| Publication status | Published - 29 Dec 1992 |
